1. Batawi S, Tarazan N, Al-Raddadi R, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health and Quality of Life Outcomes. 2019;17(1):101. DOIhttps://doi.org/10.1186/s12955-019-1165-2 PMID:31186042

2. Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950-73. DOIhttps://doi.org/10.1016/j.jacc.2020.04.031 PMID:32311448

3. Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. J Am Coll Cardiol. 2020;75(23):2950-2973. DOIhttps://doi.org/10.1016/j.jacc.2020.04. 031 PMID:16032747

4. Dundamadappa S, Kaw G, Koteyar S, Goh J, Chee T. High-Resolution CT (HRCT) in Severe Acute Respiratory Syndrome (SARS) Patients Post Hospital Discharge: A Long-term Follow-up Study | Request PDF. In: Radiological Society of North America 2004 Scientific Assembly and Annual Meeting. RSNA; 2004.

5. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683. DOIhttps://doi.org/10.1001/jamaneurol.2020.1127 PMID:32275288

6. Montalvan V, Lee J, Bueso T, de Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clinical Neurology and Neurosurgery. 2020;194:105921. DOIhttps://doi.org/10.1016/j.clineuro.2020.105921 PMID: 32422545

7. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Eng J Med. 2020;382(20):e60. DOIhttps://doi.org/10.1056/NEJMc2009787 PMID:32343504

8. Carvalho A, Alqusairi R, Adams A, et al. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. Am J Gastroenterol. 2020;115(6):942-6. DOIhttps://doi.org/10.14309/ajg.000000 0000000667 PMID:32496741

9. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020; 8(7):738-42. DOIhttps://doi.org/10.1016/S2213-2600(20)30229-0PMID:32416769

10. Konstantinides S, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. DOI:10.1093 /eurheartj/ehz405 PMID:31504429

11. Liu C, Zhou J, Xia L, Cheng X, Lu D. 18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient with Dynamic Clinical Characteristics in Different Period. Clinical Nuclear Medicine. 2020;45(6):495-6. DOIhttps://doi.org/10.1097/RLU.0000000000003068 PMID:32332319

12. Naghavi M, Libby P, Falk E, et al. From Vulnerable Plaque to Vulnerable Patient. Circulation. 2003;108(14):1664-72. DOIhttps://doi.org/10.1161/01.CIR.0000087480.94275.97 PMID:14530185

13. Slart RHJA, Slart RHJA, Glaudemans AWJM, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Molec Imaging. 2018;45(7):1250-69. DOIhttps://doi.org/10.1007/s00259-018-3973-8 PMID:29637252

14. Papathanasiou ND, Du Y, Menezes LJ, et al. 18 F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol. 2012;85(1014):e188-e194. DOIhttps://doi.org/10.1259/bjr/16422950 PMID:21385914

15. Assessment of brain SPECT: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(1):278-85. DOI:10.1212/ WNL.46.1.278 PMID:8559404